The Medical Devices Commercialization Centre (MDCC), an Ottawa-based agency focused on commercializing medical devices innovation, has named Richard J. Meadows as its first COO. Meadows was previously a managing partner at Canadian venture capital investor CTI Life Sciences Fund. Prior to then, he worked at the Caisse de dépôt et placement du Québec and held senior executive positions in several life sciences companies. MDCC recently secured operational funding from the Canadian government.
Medical Devices Commercialization Centre (MDCC) appoints Chief Operating Officer
Dr. Tofy Mussivand CEO of the newly funded Centre of Excellence for Commercialization and Research (CECR) – The Medical Devices Commercialization Centre (MDCC) and the MDCC Board of Directors are pleased to announce the appointment of Richard J. Meadows, M.Sc., M.B.A. as COO of MDCC.
Richard has had a successful career in the commercialization of medical devices and biopharmaceuticals, as an operating line manager and consultant for BRISTOL MYERS, ASTRA, SMITH +NEPHEW, PROCTER & GAMBLE. Latterly, Richard was an entrepreneur and CEO of the first wound care company in Canada, DERMACOR; and Director of Corporate Development for Advanced Tissue Sciences in LaJolla, California, the first developers of synthetic skin. Most recently, Richard turned his skills to venture investing, first for La Caisse de Depot et Placement (CDP) a $180Billion institutional Fund in Quebec and most recently as co-founder of CTI Life Sciences Fund, a $100M life sciences Fund which had two of its co-investment companies acquired for a total aggregate consideration of over $1.6B. This garnered recognition for Richard, by FORBES in 2013, as one of the top ten Life Science Investors in North America.
The Medical Device Commercialization Center is a not-for-profit corporation. It is a collaborative network of medical device stakeholders focused on the development and commercialization of viable, safe, reliable, effective and needed medical devices developed by Canadian innovators and entrepreneurs for the global market. The MDCC initiative arose from the consensus of more than 600 stakeholders from across Canada to address an important strategic gap in the Canadian medical devices ecosystem. Canada is poised to grow from being a net importer of medical devices to becoming a net exporter.
The Centres of Excellence for Commercialization and Research (CECR) program matches clusters of research expertise with the business community to share the knowledge and resources that bring innovative products and processes to market faster. The Networks of Centres of Excellence, which manages the CECR program, operates a suite of national funding programs on behalf of the three federal granting agencies-the Natural Sciences and Engineering Research Council (NSERC), the Canadian Institutes of Health Research (CIHR), and the Social Sciences and Humanities Research Council (SSHRC)-in partnership with Industry Canada and Health Canada. NCE programs support large scale, multi-disciplinary collaborations between universities, industry, government and not-for-profit organizations.
Photo courtesy of Shutterstock